Immune Checkpoint Inhibitors for Head and Neck Squamous Cell Carcinoma

被引:0
作者
Chang, Hui-Chin [1 ,2 ]
Gau, Shuo-Yan [3 ]
机构
[1] Chung Shan Med Univ, Chung Shan Med Univ Hosp, Evidence Based Med Ctr, Taichung, Taiwan
[2] Chung Shan Med Univ, Sch Med, Taichung, Taiwan
[3] Natl Taiwan Univ, Dept & Grad Inst Business Adm, 1 Sec 4 Roosevelt Rd, Taipei 106319, Taiwan
关键词
D O I
10.1001/jamaoto.2024.3966
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
[11]   Clinical implications of hyperprogression with immune checkpoint inhibitors in patients with head and neck squamous cell carcinoma (HNSCC). [J].
Economopoulou, Panagiota ;
Spathas, Nikolaos Spiridon ;
Papaxoinis, George ;
Anastasiou, Maria ;
Gkotzamanidou, Maria ;
Kotsantis, Ioannis ;
Gavrielatou, Niki ;
Oikonomopoulos, Nikolaos ;
Kirodimos, Euthymios ;
Vagia, Elena Mihal ;
Kavourakis, George ;
Psyrri, Amanda .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[12]   Overcoming Resistance to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinomas [J].
dos Santos, Lucas, V ;
Abrahao, Carina M. ;
William, William N. .
FRONTIERS IN ONCOLOGY, 2021, 11
[13]   Efficacy and safety of immune checkpoint inhibitors in elderly patients (≥70 years) with squamous cell carcinoma of the head and neck [J].
Saleh, Khalil ;
Auperin, Anne ;
Martin, Nicolas ;
Borcoman, Edith ;
Torossian, Nouritza ;
Iacob, Mariana ;
Ferrand, Francois-Regis ;
Khalife, Nadine ;
Baste, Neus ;
Guigay, Joel ;
Le Tourneau, Christophe ;
Daste, Amaury ;
Saada-Bouzid, Esma ;
Even, Caroline .
EUROPEAN JOURNAL OF CANCER, 2021, 157 :190-197
[14]   Prognostic significance of nutritional indices in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors [J].
Miyamoto, Noriyuki ;
Takenaka, Yukinori ;
Sudo, Takato ;
Eguchi, Hirotaka ;
Tanaka, Hidenori ;
Fukusumi, Takahito ;
Takemoto, Norihiko ;
Suzuki, Motoyuki ;
Inohara, Hidenori .
ACTA OTO-LARYNGOLOGICA, 2023, 143 (10) :925-930
[15]   Immunomethylomic profiles of long-term head and neck squamous cell carcinoma survivors on immune checkpoint inhibitors [J].
Lee, Min Kyung ;
Zhang, Ze ;
Sehgal, Kartik ;
Butler, Rondi ;
Stolrow, Hannah ;
Ramush, Geat ;
Shirai, Keisuke ;
Koestler, Devin C. ;
Salas, Lucas A. ;
Wiencke, John K. ;
Haddad, Robert ;
Kelsey, Karl T. ;
Christensen, Brock C. .
EPIGENOMICS, 2024, 16 (11-12) :799-807
[16]   Inhibition of PNCK inflames tumor microenvironment and sensitizes head and neck squamous cell carcinoma to immune checkpoint inhibitors [J].
Ding, Qin ;
Weng, Youliang ;
Li, Ying ;
Lin, Wanzun ;
Lin, Xiaosan ;
Lin, Tingting ;
Yang, Hanxuan ;
Xu, Wenqian ;
Wang, Jianming ;
Ying, Hongmei ;
Qiu, Sufang .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (10)
[17]   DNA methylation profiling in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors. [J].
Starzer, Angelika Martina ;
Heller, Gerwin ;
Tomasich, Erwin ;
Feldmann, Katharina ;
Hatziioannou, Teresa ;
Traint, Stefan ;
Minichsdorfer, Christoph ;
Schwarz-Nemec, Ursula ;
Nackenhorst, Maja ;
Muellauer, Leonhard ;
Preusser, Matthias ;
Berghoff, Anna Sophie ;
Fuereder, Thorsten .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[18]   No prime time yet for checkpoint inhibitors in localised head and neck squamous cell carcinoma [J].
Voortman, Jens .
LANCET ONCOLOGY, 2024, 25 (05) :533-534
[19]   Obesity and Survival After Immune Checkpoint Inhibition for Head and Neck Squamous Cell Carcinoma [J].
Mastrolonardo, Eric V. ;
Llerena, Pablo ;
Lu, Joseph ;
Nunes, Kathryn ;
Choi, Grace K. ;
Amin, Dev ;
Bridgham, Kelly M. ;
Campbell, Daniel ;
Philips, Ramez ;
Cognetti, David M. ;
Luginbuhl, Adam J. ;
Curry, Joseph M. .
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2024, 150 (08) :688-694
[20]   Gene mutation analysis and immune checkpoint therapy in head and neck squamous cell carcinoma [J].
Hua Yang ;
Yuxue Wei ;
Gangli Liu .
Oncology and Translational Medicine, 2022, 8 (01) :36-42